PRAME/EZH2-mediated regulation of TRAIL: a new target for cancer therapynte (2013)
Source: Current Molecular Medicine. Unidade: ICB
Assunto: IMUNOLOGIA
ABNT
DE CARVALHO, D. D. et al. PRAME/EZH2-mediated regulation of TRAIL: a new target for cancer therapynte. Current Molecular Medicine, v. 13, n. 2 p. 296-304, 2013Tradução . . Acesso em: 04 jun. 2024.APA
De Carvalho, D. D., Mello, B. P., Pereira, W. O., & Amarante-Mendes, J. G. P. (2013). PRAME/EZH2-mediated regulation of TRAIL: a new target for cancer therapynte. Current Molecular Medicine, 13( 2 p. 296-304).NLM
De Carvalho DD, Mello BP, Pereira WO, Amarante-Mendes JGP. PRAME/EZH2-mediated regulation of TRAIL: a new target for cancer therapynte. Current Molecular Medicine. 2013 ; 13( 2 p. 296-304):[citado 2024 jun. 04 ]Vancouver
De Carvalho DD, Mello BP, Pereira WO, Amarante-Mendes JGP. PRAME/EZH2-mediated regulation of TRAIL: a new target for cancer therapynte. Current Molecular Medicine. 2013 ; 13( 2 p. 296-304):[citado 2024 jun. 04 ]